Latest Stories
COVID-19 & CancerFreeGuest Editorial
The past two decades have brought hope to myeloma patients, as the majority benefit from the significant advances in chemotherapy.
Hearn Jay Cho, MD, PhD
Associate professor, Multiple Myeloma Center of Excellence, Tisch Cancer Institute, Icahn School of Medicine at Mt. Sinai; Chief medical officer, The Multiple Myeloma Research Foundation
